Skip to main content

Table 1 Anti-VEGF drugs and their approved indications

From: The Tie2 signaling pathway in retinal vascular diseases: a novel therapeutic target in the eye

Drug Approved indications
Ranibizumab [6] nAMD, DR, DME, RVO, myopic CNV
Aflibercept [7] nAMD, DR with DME, DME, RVO
Brolucizumab [8] nAMD
Bevacizumab [9] None (but often used for all of the above)